"The cases raise philosophical and ethical issues about the commercialization of the human body," says attorney Rebecca Gilsenan of the firm Maurice Blackburn in Sydney.
This outside non-conflicted party, (external monitor) could help to scrutinize, mitigate, and provide comprehensive guidance on ethical, social, cultural and commercialization issues by undertaking periodic assessments, while working alongside the team itself, by helping to assess policies and decisions and give objective advice throughout the partnership's progress.
Some authors have argued that a regulated market in oocytes could minimize ethical concerns raised by the commercialization of oocytes and could be consistent with respect for women (Resnik 2001; Gruen, 2007).
"As a global leader in the medical device industry, Synthes has a long reputation for setting the highest legal and ethical standards in the development and commercialization of medical products," the statement said.
Below, we present each of these issues, paying particular attention to the ethical, legal, and social aspects of commercialization and human microbiome research.
The growth of this industry introduces several ethical, legal and social concerns about the commercialization of human microbiome research.
There are broader ethical, legal and social implications associated with commercialization and human microbiome research, which should be considered in future research.
In this article, we document several ethical, legal, and social challenges associated with the commercialization of human microbiome research, focusing particularly on how this research is mobilized within economic markets for new public health uses.
To date, there is a dearth of research as to how the commercialization of human microbiome research might further compound the ethical, legal, and social issues debated in the context of maintenance or restoration of good physical health and the prevention of disease or illness.
Serious ethical questions were raised over issues associated with privacy, ownership and the commercialization of genetic material in a resource-poor setting such as Tonga, which is ruled by an island monarchy.
To understand the ethical issues involved in donation and control of biological material as well as commercialization.
